e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
Agarwal Ritesh, Aggarwal Ashutosh N., Dhooria Sahajal, Singh Sehgal Inderpaul, Garg Mandeep, Saikia Biman, Behera Digambar, Chakrabarti Arunaloke
Source:
Eur Respir J 2016; 47: 490-498
Journal Issue:
February
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Agarwal Ritesh, Aggarwal Ashutosh N., Dhooria Sahajal, Singh Sehgal Inderpaul, Garg Mandeep, Saikia Biman, Behera Digambar, Chakrabarti Arunaloke. A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J 2016; 47: 490-498
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
Source: Eur Respir J, 52 (3) 1801159; 10.1183/13993003.01159-2018
Year: 2018
Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2014; 43: 1487-1500
Year: 2014
Omalizumab in patients with allergic bronchopulmonary aspergillosis (ABPA): a multicenter case series study in Spain
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009
Clinical presentation in 12 patients with allergic bronchopulmonary aspergillosis
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
Clinical characteristics and outcome of patients with allergic bronchopulmonary aspergillosis
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017
Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 237s
Year: 2003
Itraconazole and allergic bronchopulmonary aspergillosis: long-term follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 432s
Year: 2001
Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA).
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
A randomized, placebo-controlled trial using anti-IgE to treat allergic bronchopulmonary aspergillosis
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease?
Source: Eur Respir Rev 2010 19: 261-263
Year: 2010
Risk factors for allergic bronchopulmonary aspergillosis in paediatric patients with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations
Source: Eur Respir Rev 2014; 23: 149-152
Year: 2014
Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis
Source: Eur Respir J, 56 (2) 2000175; 10.1183/13993003.00175-2020
Year: 2020
Effect of itraconazole therapy on disease course in 3 cases of allergic bronchopulmonary mycosis presented as refractory asthma
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008
Living with allergic bronchopulmonary aspergillosis
Source: Breathe, 15 (2) 108; 10.1183/20734735.0170-2019
Year: 2019
Airway remodelling easily develops in patients with allergic bronchopulmonary aspergillosis
Source: Annual Congress 2009 - Airways remodelling
Year: 2009
Incidence of allergic asthma in patients with sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 232s
Year: 2006
Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis
Source: Eur Respir Rev 2010 19: 349-351
Year: 2010
A randomized controlled study of omalizumab in children with moderate-to-severe persistent allergic asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept